ETtech Exclusive: Naveen Tahilyani steps down as Tata Digital CEO after just a year at the helm
Tata Digital
CEO and MD
Naveen Tahilyani
has stepped down just a year after being handpicked by Tata Sons Chairman N Chandrasekaran to steady the group's digital commerce ambitions. His abrupt exit underscores the
Tata group
's ongoing struggle to stabilise leadership at its much-hyped superapp venture,
Tata Neu
.
Tahilyani, a Tata veteran who was previously CEO of Tata AIA Life Insurance, was tasked with bringing executional rigour, financial discipline, and consumer focus to a fragmented digital portfolio spanning BigBasket, 1mg,
Tata Cliq
, Tata
Croma
, and the Neu app. His mandate: fix the superapp's faltering strategy and stitch together the group's digital assets into a cohesive platform.
UK-headquartered life insurer Prudential plc on Thursday announced Tahilyani's appointment as regional CEO for India, Africa, the Philippines, Cambodia, Laos and Myanmar, with additional responsibility for the health vertical.
Over the past few months, however, Tahilyani's role was gradually narrowed as plans emerged to carve out BigBasket and 1mg for separate fundraises and eventual IPOs.
This marked the end of the road for Tata Digital as a unified digital platform seeking external capital—undercutting the very premise of the superapp strategy Tahilyani had brought in to scale. Tata Neu, the group's superapp, launched in April 2022 aimed at consolidating its various consumer-facing digital businesses into one integrated platform.
'There was angst that independent business units like 1mg and BigBasket weren't allowed operational freedom,' said a person familiar with internal discussions. 'Tahilyani began shifting Tata Neu's positioning from a central command to a shared digital platform,' said a person in the know.
' It was clear that Tata Digital as an entity had become less relevant with BigBasket and 1mg in talks to raise independent funding. Plans to go to market to shore up capital as consolidated unit never frutified,' another person close to the matter said on the condition of anonymity. ET reported on April 7 that that the Tata group is preparing to raise $1.3 billion for its digital assets BigBasket and 1mg.
Strategy changes, limited traction
Under Tahilyani, the group recalibrated focus on core Tata-owned brands such as Croma and Tata Cliq. Backend integration plans across BigBasket, 1mg, and Tata Cliq were put on hold to preserve brand identities and avoid a clunky user experience—an issue that plagued Neu's early rollouts.
It accounted for less than 10% of gross sales for BigBasket and 1mg, according to insiders, signalling limited consumer adoption and weak cross-platform synergies.
'There's now a clear view that unless Neu delivers a seamless, value-led experience, it cannot subsume the identities of stronger consumer brands,' one source said.
Still, Tahilyani had laid down some groundwork. He was working closely with unit heads to align strategies and had approved 1mg's upcoming offline expansion into standalone pharmacies and diagnostic labs, as reported by ET on May 14.
Leadership churn continues
Tahilyani's tenure came on the back of continued leadership churn at Tata Digital. Since the exits of Myntra founder Mukesh Bansal in 2022 and multiple senior leaders over the past two years, the company has seen successive overhauls of its top team, including one initiated under Tahilyani himself.
Chandrasekaran, who chairs Tata Digital's board, had reportedly grown impatient with Neu's sluggish progress and had hoped Tahilyani would accelerate execution and prepare the business for possible external investment or eventual IPOs of BigBasket and 1mg.'This was always going to be a tough turnaround,' a senior executive said. 'The digital foundation is in place, but scale and traction remain elusive.'
The Tata group had renewed its Indian Premier League (IPL) title sponsorship for another five years to boost Neu's visibility, signalling continued investment in its digital play.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
9 minutes ago
- Indian Express
Will scotch get cheaper for Indian consumers after UK trade deal? Not by much, say experts
Scotch may get cheaper, but don't expect much relief at the liquor store. Tariffs on UK imports have been halved under the India-UK trade deal, but higher state-level taxes mean consumer prices may only dip 8-10 per cent, industry experts said. On the supply side, the reduction in customs duty by half to 75 per cent may boost margins for both British distillers and Indian producers who blend imported scotch with locally made whisky, they added. 'Customs duty typically accounts for around 20 per cent of the MRP across the country, while the bulk of taxes are imposed by the states. A reduction in duty by half could bring down consumer prices only by 8-10 per cent,' an industry representative said on condition of anonymity. Under the trade deal, India will immediately reduce tariffs on scotch and blended whisky imports by half to 75 per cent, and then gradually to 40 per cent over ten years, once the deal is ratified domestically by the two countries. The revision will apply to both bottled-in-origin (BIO) and bulk imports. According to Anant S Iyer, director-general of the Confederation of Indian Alcoholic Beverage Companies (CIABC), the tariff reduction could lead to newer scotch brands entering the domestic market with competitive pricing. 'Our fear is that a lot of new scotch brands from the UK can come in. These brands may not be famous here today, but they can come in at really aggressive prices that are comparable to Indian premium whisky. Already, some standalone importers are bringing in BIO whisky under 150 per cent duty with aggressive pricing,' Iyer said. Popular British scotch brands that could become slightly cheaper include Chivas Regal, Ballantine's, Glenlivet, Glenfiddich, and Johnnie Walker. Whisky was the UK's fifth-largest export product to India in 2024-25, valued at roughly $260 million, up 16 per cent from 2023-24. 'Import duties contribute only a fraction of the final price, with state excise, logistics, and distributor margins forming a large share of consumer cost. From a market standpoint, the FTA is more likely to influence product availability and premiumisation than spark a sudden demand surge. UK whisky makers may use this as an opportunity to expand brand presence,' said Naveen Malpani, Partner and Consumer Industry Leader, Grant Thornton Bharat. Industry expert Vinod Giri said a brand like Black Label in Delhi, priced at around Rs 3,500, may only get Rs 200-300 cheaper if the entire duty cut is passed on. While the reduction in consumer prices may not be much, British exporters and domestic producers who blend imported scotch could see their margins improve. Scotch is typically blended with Indian-made whisky in proportions ranging from 2 to 30 per cent, depending on the product's price segment. Popular whisky brands that blend imported scotch include Blenders Pride and McDowell's No. 1. 'Any duty reduction on Scotch whisky means the cost of production for Indian whisky makers who import it for blending goes down to that extent. While it's not likely to reflect in consumer prices, the fact is that if their costs go down, their bottom lines improve,' Giri said. 'Indian blenders will have savings per case. It depends on how much quantity of vatted malt scotch is used in the blends, and hence there will certainly be savings for them,' Iyer added. According to Giri, the reduction in customs duty will also result in bottled-in-India (BII) whisky becoming BIO over a period of 3-4 years. 'With standard Scotch whisky, if the entire duty cut is passed on, prices may drop by Rs 100-150 a bottle, bringing them close to BII whisky, which sells for around Rs 1,500. BII is also Scotch, just imported in bulk to avoid duties on packaging and other costs,' he said. 'But with the new duty set to drop to 75 per cent and then gradually to 40 per cent, it makes little commercial sense to bottle locally, invest in factories, and deal with operational hassles. Production costs are already lower in Scotland due to scale efficiencies, so they might as well ship scotch bottled from there and improve margins,' Giri added. 100 Pipers, Teacher's, Black Dog, and Black & White are among big brands that bottle imported scotch in India. Scotch distillers in the UK have welcomed the reduction in tariffs, which will give them greater access to the world's biggest whisky market by volume. 'The deal will support long term investment and jobs in our distilleries in Speyside and our bottling plant at Kilmalid and help deliver growth in both Scotland and India over the next decade,' said Jean-Etienne Gourgues, Chairman and CEO of Chivas Brothers, the firm behind popular whisky brands such as Chivas Regal and Ballantine's. Aggam Walia is a Correspondent at The Indian Express, reporting on power, renewables, and mining. His work unpacks intricate ties between corporations, government, and policy, often relying on documents sourced via the RTI Act. Off the beat, he enjoys running through Delhi's parks and forests, walking to places, and cooking pasta. ... Read More
&w=3840&q=100)
Business Standard
8 hours ago
- Business Standard
India-UK trade pact: Tariff cut may not impact Scotch whisky retail prices
The India-UK free trade agreement (FTA), under which tariffs on whisky and gin have been halved from 150 per cent to 75 per cent, which will further fall to 40 per cent in a decade's time, will not necessarily impact prices of Scotch whisky and gin for Indian consumers. According to a May 2025 report from the International Wine & Spirit Research (IWSR), blended Scotch grew the strongest of all the large whisky categories in India in 2024, with volumes rising by medium single digits and sales more than doubling since 2020. India is known to be a whisky market, with widespread national sales. However, while the data company's forecasts anticipated an upside from the FTA, it added that its impact should not be overestimated. 'While tariffs have been slashed from 150 per cent to 75 per cent, the impact on shelf prices is closer to 10 per cent and it is not a given that this will be passed on to consumers,' it had stated in the 2025 executive summary. The revised tariffs will apply to both bottled-in-origin (BIO) and bulk imports. Industry executives agree, stating that tariffs make up only up to 15 per cent of the final retail price, and with state taxes and costs for distribution and marketing, prices could be down by a mere 10 per cent. This may not be passed on to consumers, they said on the condition of anonymity. A senior commerce ministry official said that a major portion of whisky imports into India are used in the manufacture of blended whisky, whose production is set to rise due to cheaper raw material. 'We are foreseeing significant strategic and cost advantages from this development. We have estimated our Scotch requirements at over ₹250 crore in 2025-26 (FY26), and this treaty represents a substantial opportunity for value creation,' said Abhishek Khaitan, managing director at Radico Khaitan, one of the largest importers of Scotch whisky. Some liquor players also believe that the FTA will help consumers have access to premium Scotch whisky at reduced prices. 'The UK FTA is a positive move for the Scotch whisky segment, and it will enhance accessibility and affordability for Indian consumers. For import-driven portfolios like ours, this could fast-track category adoption, bring price parity closer to Indian Made Foreign Liquor (IMFL), and enable deeper reinvestment into consumer-building efforts,' said Debashish Shyam, cofounder and director, Ardent Alcobev, which sells Dram Bell blended Scotch whisky. However, the real benefit, Shyam added, will depend on how quickly the duty reductions are implemented, and whether the states align their tax structures accordingly. Spirits made up 51.2 per cent of the total beverage alcohol market in 2024, dominated by whisky. According to the data company, India consumed 258,750 under-9-litre cases of whisky in 2024, which is set to witness a compound annual growth rate (CAGR) of 3.1 per cent from 2024 to 2029. These included 8,509.60 cases of Scotch whisky, the company stated, adding that India is set to become the biggest Scotch market in the world by 2027.
Time of India
9 hours ago
- Time of India
Experts flag UK-India FTA over patent terms, access to drugs
Mumbai: Experts in intellectual property law and civil society groups in India have raised concerns that provisions in the UK-India Free Trade Agreement , Comprehensive Economic and Trade Agreement (CETA), may dilute compulsory licensing norms and jeopardise future access to affordable lifesaving medicines. As part of the Indian Patent Act, the country has the rights to invoke compulsory license for any lifesaving medicines or vaccines and call upon domestic generic players to supply it during a national emergency in the public interest. Explore courses from Top Institutes in Please select course: Select a Course Category others Digital Marketing Data Science Project Management Others CXO Healthcare Operations Management healthcare PGDM MCA Artificial Intelligence Degree Product Management Finance Data Analytics Leadership Cybersecurity Public Policy Data Science Management Technology Design Thinking MBA Skills you'll gain: Duration: 16 Weeks Indian School of Business CERT - ISB Cybersecurity for Leaders Program India Starts on undefined Get Details KM Gopakumar, co-convenor of Working Group on Access to Medicines and Treatment, said the deal amounts to giving a backdoor entry to TRIPS (Trade Related Intellectual Property Rights) plus provisions and goes beyond the minimum standards set by the World Trade Organization, which India has so far resisted in multilateral trade forums. The group said the UK-India FTA provisions on patents tilt the balance in favour of the patent owner and undermines access to medicines. The UK-India FTA says, "The parties recognise the preferable and optimal route to promote and ensure access to medicines is through voluntary mechanisms, such as voluntary licensing , which may include technology transfer on mutually agreed terms." Biswajit Dhar, retired professor of economics at Jawaharlal Nehru University, noted that India was moving away from its sovereign rights by placing emphasis on voluntary license (VLs). "It will kill the essence of the compulsory licensing mechanism and even within the legal framework, India has issued only one CL to Natco Pharma (for Bayer's kidney cancer drug sorafenib)," he noted. He said VLs come with restrictions of pricing that are determined by the innovator Big Pharma companies. "Often voluntary license contains onerous conditions on the licensee and fails to bring sharp price reduction compared to the compulsory licenses," Dhar added. Gopakumar said that India places a higher threshold for examination and grant of patents, but if the FTA deal is any indication, it may result in "functional harmonization" and lead to dilution in the grant of patent. However, a few other patent experts told ET that the FTA seeks to keep a balance between India's current IP regime with public health and the UK's preference of protecting various IP rights. The FTA seeks to create a Working Group on IPR. On patents, India's important safeguards such as Section 3(d) (which blocks evergreening of patents) of the Indian Patent Act, and oppositions have not been disregarded and it should help in India's status as the world's generic drug manufacturer and protect access to medicines for domestic patients.
